While several studies of glioma patient samples [51, 52] found no correlation between IDH1 mutations and tumour invasiveness, another study [53] in a fibrosarcoma cell line with endogenous IDH1-R132C showed a requirement for mutant IDH1 protein for cell survival. This evidence concerns the gene IDH1 and neoplasm.